SEC Form 4 · accession 0001209191-16-089496

ACORDA THERAPEUTICS INC · ACOR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jan 4, 2016

Accepted (ET)

Jan 6, 2016 · 8:05 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001008848

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Jan 4, 2016	M	542	$22.13	A	542	D
Common Stock^F1	Jan 4, 2016	M	2,689	$17.85	A	3,231	D
Common Stock^F1	Jan 4, 2016	M	10,000	$18.21	A	13,231	D
Common Stock^F1,F2	Jan 4, 2016	S	13,131	$41.846	D	100	D
Common Stock^F1	Jan 4, 2016	S	100	$42.26	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Non-Employee Stock Option^F1,F3	$22.13	Jan 4, 2016	M	542	D	—	Feb 14, 2017	Common Stock	542	D
Non-Employee Stock Option^F1,F4	$17.85	Jan 4, 2016	M	2,689	D	—	Feb 1, 2017	Common Stock	2,689	D
Non-Employee Stock Option^F1,F5	$18.21	Jan 4, 2016	M	10,000	D	—	Aug 6, 2017	Common Stock	10,000	D

F1Exercises and sales pursuant to a 10b5-1 plan.
F2The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $41.22 to $42.07 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3The shares subject to these options vested in installments and were fully vested on February 14, 2008.
F4The shares subject to these options vested in installments and were fully vested on February 1, 2008.
F5The shares subject to these options vested in installments and were fully vested on June 5, 2008.